A son is sharing his heartbreaking experience of his mother enduring prolonged delays at a hospital that failed to meet crucial deadlines and targets for patient care. The Parliamentary and Health Service Ombudsman has directed the Mid and South Essex NHS Foundation Trust to apologize to the family of a 67-year-old woman, identified as Mrs S, due to significant lapses in her cancer diagnosis and treatment.
Tragically, Mrs S, a retired history teacher and mother of two from Chelmsford, passed away in 2023 as a result of delays in receiving her diagnosis and subsequent treatment. Despite her initial visit to the GP in January 2023 for abdominal bloating, it took extensive time for her to undergo a CT scan, biopsy, and receive a diagnosis of ovarian cancer. The delays in her care meant that by the time treatment was arranged, she was too unwell to benefit from it.
The Ombudsman highlighted that the timeframes Mrs S experienced were far below the standards established by NHS England, with her diagnosis taking 49 days and treatment initiation delayed by an additional 81 days. These delays significantly impacted Mrs S’s chances of receiving timely care.
Following her son’s complaints about his mother’s treatment, the hospital trust acknowledged a decline in meeting cancer treatment targets, with data indicating a decrease in timely treatments for cancer patients. The Ombudsman emphasized the distress caused to Mrs S and her family due to the trust’s failings, recommending a thorough review of waiting times and service improvements.
Mrs S’s son expressed ongoing distress over the lack of support his mother received before her passing, attributing it to continuous delays in her care. He lamented the missed opportunities for timely diagnosis and treatment that could have potentially extended her life and improved their quality time together.
The MSE NHS Foundation Trust affirmed its commitment to addressing the issues raised, pledging to enhance its performance against national targets and implement new technologies to streamline resource allocation and enhance capacity for cancer appointments. The trust’s CEO acknowledged the challenges in managing increased demand for diagnostic services and outlined plans for expedited treatment processes and improved patient outcomes, especially in cancer care.
In conclusion, the Ombudsman’s intervention has prompted the trust to reevaluate its practices and strive for adherence to national guidelines, ensuring that future patients and families receive care within recommended timeframes.